
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
-Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its comprehensive transformation plan.- - The Company now expects …